Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2025-12-24 @ 4:31 PM
NCT ID:
NCT06144866
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥ 20 years
2. Having AF diagnosis
3. Under NOACs therapy including dabigatran, rivaroxaban, apixaban and edoxaban.
4. Admitted for acute IS, transient ischemic attack (TIA), ICH or major bleeding
Exclusion Criteria:
1. The ICH is resulted from trauma.
2. Decline the inform consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT06144866
Study Brief:
Protocol Section:
NCT06144866